Trial Profile
RCT of Duloxetine and Pregabalin for the Treatment of Gulf War Illness in Veterans
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Pregabalin (Primary)
- Indications Persian-gulf-syndrome
- Focus Adverse reactions
- Acronyms REGIONS
- 07 Jan 2020 Status changed from active, no longer recruiting to discontinued.
- 24 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 27 Jul 2018 Planned number of patients changed from 180 to 162.